About Dreampath Diagnostics
Dreampath Diagnostics is a Healthcare company based in Strasbourg (France) founded in 2015, and was acquired by Halma in July 2026. Pathology sample management and traceability solutions are provided for laboratories. Its focus areas include Services for Healthcare Providers and Medical Records Review Services.
Company details
Dreampath Diagnostics was established in 2015 in Strasbourg, France, within the diagnostics sector. Solutions for pathology sample management and traceability are developed for laboratory use. Visibility into sample locations and chain-of-custody is enabled through these systems. Manual tasks in handling, sorting, archiving, and retrieving tissue samples are reduced to streamline workflows. Requirements for sample retention and needs for deeper analysis are addressed in the operations.
- Headquarters Strasbourg, France
- Stage Acquired
- SectorsHealthcare
- Website dreampathdx.net
- Acquired by Halma (Jul 2026)
Investors in Dreampath Diagnostics
Dreampath Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Halma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Safety, health, and environmental technologies are developed and supplied internationally. | 1894 | halma.com | Amersham, United Kingdom |
Investor details for Dreampath Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dreampath Diagnostics
11 people are tracked at Dreampath Diagnostics (6 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Matthew Gotto | Regional Sales Director - Southeast | Leadership |
Autumn Papania | Regional Sales Director | Leadership |
Pablo Jordan | CEO | Leadership |
Alyssia Dugo | Regional Sales Director | Leadership |
Jessica Manney | Senior Regional Sales Director | Leadership |
Dreampath Dx | Sales Director | Leadership |
Valérie Wilhelm | EVP R&d & Operations | Team |
Valérie Costes - Martineau | Pr. Valérie Costes-martineau | Team |
Jeffrey Dupont | Global Service Manager | Team |
J.r. Nieman | Sales | Team |
Emeline Beaudri | Tech Support And E&t Manager | Team |
Complete people profiles for Dreampath Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dreampath Diagnostics
2 dated milestones of Dreampath Diagnostics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Dreampath Diagnostics is founded.
- Exit Acquired by Halma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dreampath Diagnostics
Dreampath Diagnostics was founded in 2015.
Dreampath Diagnostics is headquartered in Strasbourg, France. It is registered at Strasbourg, Grand Est, France.
Dreampath Diagnostics was established in 2015 in Strasbourg, France, within the diagnostics sector. Solutions for pathology sample management and traceability are developed for laboratory use. Visibility into sample locations and chain-of-custody is enabled through these systems. Manual tasks in handling, sorting, archiving, and retrieving tissue samples are reduced to streamline workflows. Requirements for sample retention and needs for deeper analysis are addressed in the operations.
Dreampath Diagnostics has 1 investor. Key investors include Halma.
Yes. Dreampath Diagnostics was acquired by Halma in July 2026.